This month's preferred stock IPO market is frozen, dominated by “Par Cross” and “Insider Buying” alerts, reflecting investor uncertainty due to trade tensions. The trade war and tariffs have created significant market volatility, causing companies to withdraw earnings guidance and defer investment decisions. Preferred stocks and baby bonds offer fixed payments, making them attractive during uncertain times, as they provide a “known return” amidst market unpredictability.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
![]() 0HAV 1 month ago | Other | $0.25 Per Share |
![]() 0HAV 4 months ago | Other | $0.25 Per Share |
![]() 0HAV 7 months ago | Other | $0.24 Per Share |
![]() 0HAV 9 months ago | Other | $0.24 Per Share |
![]() 0HAV 28 Mar 2024 | Other | $0.24 Per Share |
25 Feb 2025 Date | | - Cons. EPS | 1.11 EPS |
25 Nov 2024 Date | | - Cons. EPS | - EPS |
18 Nov 2024 Date | | - Cons. EPS | - EPS |
22 Aug 2024 Date | | - Cons. EPS | - EPS |
21 Aug 2024 Date | | - Cons. EPS | - EPS |
![]() 0HAV 1 month ago | Other | $0.25 Per Share |
![]() 0HAV 4 months ago | Other | $0.25 Per Share |
![]() 0HAV 7 months ago | Other | $0.24 Per Share |
![]() 0HAV 9 months ago | Other | $0.24 Per Share |
![]() 0HAV 28 Mar 2024 | Other | $0.24 Per Share |
25 Feb 2025 Date | | - Cons. EPS | 1.11 EPS |
25 Nov 2024 Date | | - Cons. EPS | - EPS |
18 Nov 2024 Date | | - Cons. EPS | - EPS |
22 Aug 2024 Date | | - Cons. EPS | - EPS |
21 Aug 2024 Date | | - Cons. EPS | - EPS |
Diagnostics & Research Industry | Healthcare Sector | Mr. Padraig McDonnell CEO | LSE Exchange | US00846U1016 ISIN |
United States Country | 17,400 Employees | 1 Apr 2025 Last Dividend | 3 Nov 2014 Last Split | - IPO Date |
Agilent Technologies, Inc. stands as a global provider offering application-focused solutions primarily to the life sciences, diagnostics, and applied chemical sectors. The company propagates its mission across three distinct segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab, ensuring a broad spectrum of scientific research, diagnostic, and analytical needs are met worldwide. Since its establishment in 1999, Agilent has cemented its headquarters in Santa Clara, California, from where it orchestrates its global operations, offering an expansive portfolio through direct sales, distributors, resellers, and electronic commerce frameworks.